Skip to content
2000
Volume 8, Issue 2
  • ISSN: 1573-4137
  • E-ISSN: 1875-6786

Abstract

Magnetic iron oxide nanoparticles (MION) with unique surface properties have been widely used in various fields of sciences such as biomedicine. In addition to complicated chemical methods of iron oxide nanoparticles synthesis, there are great concerns regarding their application in vivo. The aims of this study were to investigate both the biologic synthesis of iron nanoparticles and toxic effects of MIONs on red blood cells from healthy and thalassemic blood donors. A Gram negative bacterium was isolated from iron enriched media and was identified as an Acinetobacter radioresistens strain by 16s RNA sequencing. The FTIR, SEM-EDX and XRD analysis results showed that the isolate could synthesize MIONs (≤ 104 nm) in filter sterilized iron enriched media (media with high iron ions) under strict aerobic condition. Further, our results indicated that although none of bacterial or artificial nanoparticles are toxic to Gram positive or negative bacteria but depending of their size and concentration could cause lysis in red blood cells (RBC) and as well as white blood cells (WBC). Toxicity of commercial and bacterial MIONs on peripheral blood cells was evaluated by monitoring hemagglutination, hemolysis and morphological changes. Our data also indicated while lysis occurs in low concentration of nanoparticles but severe hemagglutination is seen in samples treated with commercial nanoparticles (8 nm) beginning at 50μg/mL. The rate of hemolysis and morphological changes was intensified by increasing the concentrations of MIONs. In contrast, the bacterial MIONs did not induce any morphological changes on peripheral blood cells. To our knowledge, this is the first report about construction of nontoxic MIONs by Acinetobacter radioresistens.

Loading

Article metrics loading...

/content/journals/cnano/10.2174/157341312800167687
2012-04-01
2025-09-16
Loading full text...

Full text loading...

/content/journals/cnano/10.2174/157341312800167687
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test